Bristol-Myers Squibb $2PR (BMYMP) Revenue by Year
Bristol-Myers Squibb $2PR generated $48.2B in revenue in fiscal year 2025. This represents a decrease of 0.2% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $48.5B in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Bristol-Myers Squibb $2PR has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BMYMP Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
BMYMP Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Bristol-Myers Squibb $2PR financials
Frequently Asked Questions
Bristol-Myers Squibb $2PR generated $48.2B in revenue in fiscal year 2025.
Bristol-Myers Squibb $2PR (BMYMP) revenue fell by 0.2% year over year, from $48.3B to $48.2B in fiscal year 2025.
Bristol-Myers Squibb $2PR (BMYMP) reported $48.5B in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
Across the 15 fiscal years this page covers, Bristol-Myers Squibb $2PR (BMYMP) revenue went from $21.2B in fiscal year 2011 to $48.2B in fiscal year 2025.
Bristol-Myers Squibb $2PR (BMYMP) reported $11.5B in revenue in Q1 2026. This represents an increase of 2.6% from the same quarter a year earlier.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Bristol-Myers Squibb $2PR (BMYMP) reported on that line in every period on record.